Corcept Therapeutics (CORT) Non-Current Debt (2012 - 2016)

Corcept Therapeutics has disclosed Non-Current Debt across 5 years of filings, most recently posting $3.7 million for Q2 2016.

• Non-Current Debt for Q2 2016 came in at $3.7 million, down 80.7% year-over-year; the trailing twelve-month figure through Jun 2016 was $3.7 million (down 80.7% YoY), and the FY2015 annual result was $12.5 million, down 48.79% from the prior year.
• Non-Current Debt came in at $3.7 million for Q2 2016 at Corcept Therapeutics, down from $8.7 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $30.2 million in Q2 2013 to a low of $3.7 million in Q2 2016.
• The 5-year median for Non-Current Debt is $26.8 million (2014), against an average of $22.8 million.
• Across the five-year window, Non-Current Debt rose 6.41% in 2013 and plunged 80.7% in 2016, its largest moves.
• Corcept Therapeutics' Non-Current Debt stood at $29.0 million in 2012, then rose by 1.01% to $29.3 million in 2013, then decreased by 16.57% to $24.5 million in 2014, then slumped by 48.79% to $12.5 million in 2015, then slumped by 70.11% to $3.7 million in 2016.
• The last three Non-Current Debt figures came in at $3.7 million (Q2 2016), $8.7 million (Q1 2016), and $12.5 million (Q4 2015), per Business Quant data.